Kalijev Klorid B. Braun (Potassium Chloride)

Kalijev Klorid B. Braun is used in clinical situations that involve potassium deficiency or the need for electrolyte replacement.

• Hypokalemia: restores normal serum potassium concentrations in patients with low potassium levels.
• Potassium supplementation: provides supplemental potassium for patients on diuretics or other potassium‑depleting therapies.
• Electrolyte replacement therapy: maintains electrolyte balance during surgery, critical care, or severe fluid loss.

• Potassium Chloride dissociates after intravenous administration, releasing potassium ions that enter the extracellular fluid. The increased extracellular potassium concentration drives diffusion into cells via the Na⁺/K⁺‑ATPase pump, helping to re‑establish the normal transmembrane potassium gradient essential for nerve impulse transmission, muscle contraction, and cardiac electrophysiology.

Kalijev Klorid B. Braun may be associated with a range of adverse reactions, most of which are related to the rapid rise in serum potassium or the intravenous route.

Common Side Effects

• Mild vein irritation or pain at the injection site.
• Transient nausea or vomiting.
• Temporary headache.
• Low‑grade fever.
• Mild electrolyte imbalance other than potassium.

Serious or Rare Side Effects

• Hyperkalemia leading to cardiac arrhythmia.
• Severe allergic reaction (anaphylaxis).
• Phlebitis or thrombophlebitis.
• Rapid rise in serum potassium causing muscle weakness.
• Cardiac arrest in extreme cases.

When using Kalijev Klorid B. Braun, clinicians should observe several safety measures to minimize risk.

• Assess serum potassium: verify baseline levels before administration.
• Adjust dose in renal impairment: reduce or monitor closely.
• Avoid rapid infusion: follow recommended infusion rates to prevent hyperkalemia.
• Monitor cardiac function: continuous ECG monitoring in high‑risk patients.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium Chloride can interact with several medications, altering potassium balance or cardiac risk.

Major Interactions (Avoid)

• ACE inhibitors or ARBs: may cause additive hyperkalemia.
• Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation.
• Digoxin: heightened risk of digoxin toxicity with high potassium.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): can reduce renal potassium excretion.
• Beta‑blockers: may mask symptoms of hyperkalemia.
• Insulin or glucose therapy: can shift potassium intracellularly, affecting serum levels.